glp 1 agonists and sglt2 inhibitors combination Combining glucagon-like peptide-1 receptor (GLP-1RAs) sodium-glucose cotransporter-2 (SGLT2is) in patients with type 2 diabetes mellitus (T2DM) | Cardiovascular Diabetology GLP1 Receptor Agonists vs SGLT2-I

Mehravar S, et al

Several segments in the ECD of GCGR, the stalk between ECD and transmembrane helix 1 (TM1) of GLP-1R (residues 130135), extracellular loop 1 (ECL1) of GIPR (residues 202207), and intracellular loop 3 (ICL3) of GLP-1R and GIPR (residues 338343 and 330333, respectively) were poorly resolved and not modeled in the structures

10.1038/s41467-022-32307-y

Subsequent administration of the GLP-1 receptor agonist semaglutide (Sem) to dams in late pregnancy revealed a modest decrease in maternal food intake during initial treatment

Human data followed: a prospective, double-blind RCT in Diabetes Care found that daily administration of Lactobacillus reuteri SD5865 increased glucose-stimulated GLP-1 release by 76% compared to placebo, with corresponding increases in insulin secretion